[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100589377":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":10,"centralContacts":39,"locations":45,"responsibleParty":59,"collaborators":10,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":10,"eligibilityCriteria":66,"healthyVolunteers":63,"sex":67,"minAge":10,"maxAge":10,"enrollmentInfo":68,"targetDuration":10,"studyType":71,"phases":10,"briefSummary":72,"conditions":73,"keywords":10,"overallStatus":47,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Peking University Third Hospital","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Conservative group",null,"Don't use antiplatelet drugs or undergo patent foramen ovale closure.",[13],"Drug: Conservative treatment",{"label":15,"type":10,"description":16,"interventionNames":17},"Antiplatelet group","The application of antiplatelet drug.",[18],"Drug: Antipaletet drug",{"label":20,"type":10,"description":21,"interventionNames":22},"PFO group","Receive a patent foramen ovale closure surgery.",[23],"Procedure: Patent Foramen Ovale Closure",[25,30,34],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":10},"DRUG","Conservative treatment","Receive no antipaletet drug treatment and surgery",[9],{"type":26,"name":31,"description":32,"armGroupLabels":33,"otherNames":10},"Antipaletet drug","Use of antipaletet drugs.",[15],{"type":35,"name":36,"description":37,"armGroupLabels":38,"otherNames":10},"PROCEDURE","Patent Foramen Ovale Closure","Receive the surgery of Patent Foramen Ovale",[20],[40],{"name":41,"role":42,"phone":43,"phoneExt":10,"email":44},"Yu Fu","CONTACT","13671185050","lilac_fu@126.com",[46],{"facility":5,"status":47,"city":48,"state":10,"zip":10,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"RECRUITING","Beijing","China","CN",{"type":52,"coordinates":53},"Point",[54,55],116.39723,39.9075,{"lat":55,"lon":54},[58],{"name":41,"role":42,"phone":43,"phoneExt":10,"email":44},{"type":60,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100589377","establishment-of-a-clinical-and-prognostic-follow-up-cohort-of-migraine-patients-with-patent-foramen-ovale-100589377",false,"NCT06953622","Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale","Inclusion Criteria:\n\n* Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3);\n* Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)\u002Fright heart contrast echocardiography\n* Agree to participate in the study and sign the informed consent form.\n\nExclusion Criteria:\n\n* Can not sign the informed consent form or cooperate with follow-up.","ALL",{"count":69,"type":70},330,"ESTIMATED","OBSERVATIONAL","To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.",[74,75],"Migraine","Patent Foramen Ovale","2025-04-29",{"date":78,"type":79},"2025-05-01","ACTUAL",{"date":81,"type":79},"2024-01-01",{"date":83,"type":70},"2026-12-31",{"name":5,"class":6},1]